Search

everythinglearnresearchcommunity

for

Search:↓

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Some dibenzo compounds might help treat cancer with fewer side effects.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Neurosteroids may help metyrapone reduce cocaine addiction.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

GnRH treatment can reduce breast cancer cell invasion.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Calancardin B may help reduce inflammation in immune cells.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Analog 23 is a promising compound for prostate cancer treatment.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.